Total consideration is AU$42.35M.
FY24 revenues was $23.7M for ANZ. FY25 is on track for $25.5M.
But agree, this does seem like an opportunistic offer.
US revenues in FY24 was $98M, now an outlier.
US business is worth not much (but should be recognised as valuable) if taking the offer from the market cap.
Surprised with the market reaction with numbers now revealed, ~60% premium to current FY revenues.
A first offer is often negotiated and this might set the floor price.
- Forums
- ASX - By Stock
- MDR
- Ann: Strategic Review Update - Further Information
MDR
medadvisor limited
Add to My Watchlist
3.61%
!
8.0¢

Ann: Strategic Review Update - Further Information, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.0¢ |
Change
-0.003(3.61%) |
Mkt cap ! $50.02M |
Open | High | Low | Value | Volume |
8.4¢ | 8.5¢ | 7.9¢ | $138.3K | 1.717M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 120000 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 120000 | 0.079 |
2 | 503500 | 0.077 |
1 | 65131 | 0.076 |
4 | 229999 | 0.075 |
1 | 140000 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 100000 | 1 |
0.084 | 109379 | 2 |
0.085 | 164468 | 2 |
0.086 | 205000 | 2 |
0.087 | 304559 | 2 |
Last trade - 15.54pm 22/07/2025 (20 minute delay) ? |
Featured News
MDR (ASX) Chart |